As of the latest Form 4 filed Jul 1, 2026.
What The Travelers Companies Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 30 most recent filings for TRV.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 | 2026-06-30 | Robinson Elizabeth Director | AAward | +132.53 | $330.12 | $43.8K | No | Form 4 ↗ |
| 2026-07-01 | 2026-06-30 | Golden Russell G. Director | AAward | +140.10 | $330.12 | $46.2K | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Kess Avrohom J. Vice Chmn. & Chief Legal Off. | GGift | −1.00K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | Kess Avrohom J. Vice Chmn. & Chief Legal Off. | SSale | −6.74K | $308.78 | $2.08M | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | Kess Avrohom J., Vice Chmn. & Chief Legal Off. | FTax | −21.0K | $309.03 | $6.47M | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | Kess Avrohom J., Vice Chmn. & Chief Legal Off. | MExercise | +27.7K | $140.85 | $3.90M | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | HEYMAN WILLIAM H Vice Chairman | SSale | −1.00K | $311.00 | $311K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | HEYMAN WILLIAM H, Vice Chairman | SSale | −557.00 | $310.00 | $173K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-28 | HEYMAN WILLIAM H, Vice Chairman | MExercise | +1.56K | $189.01 | $294K | No | Form 4 ↗ |
| 2026-04-27 | 2026-04-23 | THOMSEN LAURIE J Director | GGift | −631.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | Kurtzman Diane EVP & Chief HR Officer | SSale | −1.39K | $303.42 | $421K | No | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | Kurtzman Diane, EVP & Chief HR Officer | MExercise | +1.39K | $132.58 | $184K | No | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | Kurtzman Diane, EVP & Chief HR Officer | SSale | −1.48K | $303.47 | $449K | No | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | Klein Michael Frederick EVP & President, Personal Ins. | SSale | −3.27K | $304.38 | $995K | No | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | Klein Michael Frederick, EVP & President, Personal Ins. | SSale | −6.73K | $303.47 | $2.04M | No | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | Klein Michael Frederick, EVP & President, Personal Ins. | MExercise | +10.0K | $132.58 | $1.33M | No | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | Kess Avrohom J. Vice Chmn. & Chief Legal Off. | GGift | −2.13K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | Klenk Jeffrey P. EVP & Pres., Bond & Spec. Ins. | SSale | −6.41K | $305.06 | $1.96M | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-06 | OLIVO MARIA EVP, ERM & Chief Risk Officer | SSale | −10.4K | $300.75 | $3.13M | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-06 | OLIVO MARIA, EVP, ERM & Chief Risk Officer | MExercise | +10.4K | $118.78 | $1.24M | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-06 | Klein Michael Frederick EVP & President, Personal Ins. | SSale | −10.0K | $301.18 | $3.01M | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-06 | Klein Michael Frederick, EVP & President, Personal Ins. | MExercise | +10.0K | $132.58 | $1.33M | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-06 | HEYMAN WILLIAM H Vice Chairman | SSale | −1.00K | $303.00 | $303K | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-06 | HEYMAN WILLIAM H, Vice Chairman | MExercise | +1.00K | $172.50 | $173K | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-05 | HEYMAN WILLIAM H, Vice Chairman | SSale | −5.00K | $302.00 | $1.51M | No | Form 4 ↗ |
| 2026-02-09 | 2026-02-05 | HEYMAN WILLIAM H, Vice Chairman | MExercise | +5.00K | $172.50 | $863K | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-03 | SCHERMERHORN TODD C Director | AAward | +729.00 | $288.23 | $210K | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-03 | LEONARDI THOMAS B Director | AAward | +729.00 | $288.23 | $210K | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-03 | Santana Rafael Director | AAward | +729.00 | $288.23 | $210K | No | Form 4 ↗ |
| 2026-02-05 | 2026-02-03 | Golden Russell G. Director | AAward | +729.00 | $288.23 | $210K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also TRV’s full analysis or the market-wide insider trading feed. The tabs above jump to TRV’s other SEC data.
Source: SEC Form 4 filings for TRV, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.